Meridian Bioscience joins coronavirus rally, up 28% 
 Meridian Bioscience (VIVO ) is up on average volume in reaction to its announcement that diagnostic companies and laboratories in China are using its Lyo-Ready 1-Step RT-qPCR Mix to develop screening tests for the 2019-nCoV coronavirus causing the current outbreak of respiratory illnesses.